Venous Thromboembolism Risk in Lupus Nephritis Not Limited to Class 5
This the first study to evaluate the risk for venous thromboembolism by lupus nephritis class, according to investigators.
All articles by Natasha Persaud
Calcimimetic Found More Effective in Suppressing Calcification in HD
Trial findings suggest a calcimimetic may be more effective than a VDRA at reducing calcification in patients receiving hemodialysis.
Anti-Inflammatory Drug May Improve ESA Hyporesponsiveness in HD
In a short-term trial involving hemodialysis patients, ziltivekimab significantly improved erythropoietin resistance index.
HIF-PHIs Show Short-Term Efficacy and Safety
A current meta-analysis of HIF-PHIs showed that these drugs improve the response rate of hemoglobin and decrease hepcidin levels.
Factors Contributing to Darbepoetin Responsiveness in CKD
In a Japanese study, approximately 1 in 8 CKD patients with anemia failed to respond to darbepoetin alfa therapy.
Vadadustat Noninferior to Darbepoetin in CKD
Despite favorable efficacy data, the HIF-PHI failed to demonstrate noninferiority to the ESA in patients with CKD with respect to the primary MACE safety endpoint.
Ferric Citrate May Improve Iron Parameters Better Than Ferrous Sulfate in CKD
Transferrin saturation and ferritin concentrations improved significantly more in the ferric citrate than ferrous sulfate group over 12 weeks.
Anemia Tied With IgA Nephropathy Progression
Low hemoglobin levels in patients with IgAN increase their risk for end-stage kidney disease, according to new research.
Daprodustat Noninferior to ESA in Hemodialysis Cases
In a phase 3 trial, mean hemoglobin was maintained within target range during 52 weeks of treatment with oral daprodustat.
Anemia May Increase Risk for Kidney Failure
Investigators found sex and racial differences in the risk for end-stage kidney disease among patients with CKD anemia.
-
Loading...
-
Loading...
Next post in Anemia
